Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

GBR-500 slows growth of prostate tumors in vivo

May 3, 2011

FDA grants orphan drug status to CytRx's INNO-206 in pancreatic cancer

May 2, 2011

FDA approves Fusilev in combination with 5-FU for colorectal cancer

May 2, 2011

Vandetanib launched in U.S. for advanced medullary thyroid cancer

May 2, 2011

First selective ganglioside biosynthesis inhibitors identified at Zacharon Pharma

May 2, 2011

New lysophospholipid receptor antagonists reported by Amira Pharma

May 2, 2011

MK-3475 enters phase I trial in patients with solid tumors

May 2, 2011

CH-4938056 targets microtubule-associated protein 4 to confer antitumor activity

May 2, 2011

FDA approves Zytiga in combination with prednisone for metastatic CRPC

April 29, 2011

Adherex Technologies enrolls first patient in phase II eniluracil trial

April 29, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...